Chronic liver disease mortality among male prison inmates in Texas, 1989-2003

Amy Jo Harzke, Jacques Baillargeon, David P. Paar, John Pulvino, Owen J. Murray

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

OBJECTIVES:Alcohol abuse and chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the major etiologic factors for chronic liver diseasecirrhosis (CLD) in the United States. These CLD risk factors are highly prevalent in US adult incarcerated populations, but CLD-related mortality data from these populations are lacking. The primary objective of this study was to assess CLD-related mortality over time and across categories of race-ethnicity from 1989 through 2003 among male inmates in the Texas state prison system. The secondary objective was to examine patterns of recorded underlying, intervening, and contributing causes of death for CLD-related deaths.METHODS:Prisoner decedent data were linked with Texas Vital Statistics multiple-cause-of-death data. Deaths were considered CLD-related if CLD or common sequelae were recorded as the underlying, intervening, or contributing causes of death. CLD-related crude annual death rates, 5-year average annual death rates, and average annual percentage changes were estimated.RESULTS:Among male Texas prisoners from 1989 to 2003, CLD-related deaths accounted for 16 of deaths (6884,316). CLD-related crude annual death rates were high and increased over the study period by an average of 4.5 annually, with similar rate increases across categories of race-ethnicity. CLD-related average annual death rates were higher among Hispanic prisoners than among black prisoners in each 5-year period, and were higher than those for white prisoners in the 1994-1998 and 1999-2003 periods. HBV or HCV was identified as a causal factor in more than a third (34) of CLD-related deaths.CONCLUSIONS:From 1989 to 2003, CLD-related death rates among male Texas prisoners were high and increased over time, particularly among Hispanics. Targeted prevention, screening, and treatment of CLD risk factors, especially HCV, and early detection and treatment of CLD should be considered as priorities of the US prison healthcare systems.

Original languageEnglish (US)
Pages (from-to)1412-1419
Number of pages8
JournalAmerican Journal of Gastroenterology
Volume104
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Prisons
Liver Diseases
Chronic Disease
Mortality
Liver
Prisoners
Hepacivirus
Cause of Death
Hispanic Americans
Hepatitis B virus
Vital Statistics
Chronic Hepatitis B
Virus Diseases
Population
Alcoholism

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Chronic liver disease mortality among male prison inmates in Texas, 1989-2003. / Harzke, Amy Jo; Baillargeon, Jacques; Paar, David P.; Pulvino, John; Murray, Owen J.

In: American Journal of Gastroenterology, Vol. 104, No. 6, 06.2009, p. 1412-1419.

Research output: Contribution to journalArticle

Harzke, Amy Jo ; Baillargeon, Jacques ; Paar, David P. ; Pulvino, John ; Murray, Owen J. / Chronic liver disease mortality among male prison inmates in Texas, 1989-2003. In: American Journal of Gastroenterology. 2009 ; Vol. 104, No. 6. pp. 1412-1419.
@article{c3f61e9aff8e413c8f8e7aec523f9d81,
title = "Chronic liver disease mortality among male prison inmates in Texas, 1989-2003",
abstract = "OBJECTIVES:Alcohol abuse and chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the major etiologic factors for chronic liver diseasecirrhosis (CLD) in the United States. These CLD risk factors are highly prevalent in US adult incarcerated populations, but CLD-related mortality data from these populations are lacking. The primary objective of this study was to assess CLD-related mortality over time and across categories of race-ethnicity from 1989 through 2003 among male inmates in the Texas state prison system. The secondary objective was to examine patterns of recorded underlying, intervening, and contributing causes of death for CLD-related deaths.METHODS:Prisoner decedent data were linked with Texas Vital Statistics multiple-cause-of-death data. Deaths were considered CLD-related if CLD or common sequelae were recorded as the underlying, intervening, or contributing causes of death. CLD-related crude annual death rates, 5-year average annual death rates, and average annual percentage changes were estimated.RESULTS:Among male Texas prisoners from 1989 to 2003, CLD-related deaths accounted for 16 of deaths (6884,316). CLD-related crude annual death rates were high and increased over the study period by an average of 4.5 annually, with similar rate increases across categories of race-ethnicity. CLD-related average annual death rates were higher among Hispanic prisoners than among black prisoners in each 5-year period, and were higher than those for white prisoners in the 1994-1998 and 1999-2003 periods. HBV or HCV was identified as a causal factor in more than a third (34) of CLD-related deaths.CONCLUSIONS:From 1989 to 2003, CLD-related death rates among male Texas prisoners were high and increased over time, particularly among Hispanics. Targeted prevention, screening, and treatment of CLD risk factors, especially HCV, and early detection and treatment of CLD should be considered as priorities of the US prison healthcare systems.",
author = "Harzke, {Amy Jo} and Jacques Baillargeon and Paar, {David P.} and John Pulvino and Murray, {Owen J.}",
year = "2009",
month = "6",
doi = "10.1038/ajg.2009.106",
language = "English (US)",
volume = "104",
pages = "1412--1419",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Chronic liver disease mortality among male prison inmates in Texas, 1989-2003

AU - Harzke, Amy Jo

AU - Baillargeon, Jacques

AU - Paar, David P.

AU - Pulvino, John

AU - Murray, Owen J.

PY - 2009/6

Y1 - 2009/6

N2 - OBJECTIVES:Alcohol abuse and chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the major etiologic factors for chronic liver diseasecirrhosis (CLD) in the United States. These CLD risk factors are highly prevalent in US adult incarcerated populations, but CLD-related mortality data from these populations are lacking. The primary objective of this study was to assess CLD-related mortality over time and across categories of race-ethnicity from 1989 through 2003 among male inmates in the Texas state prison system. The secondary objective was to examine patterns of recorded underlying, intervening, and contributing causes of death for CLD-related deaths.METHODS:Prisoner decedent data were linked with Texas Vital Statistics multiple-cause-of-death data. Deaths were considered CLD-related if CLD or common sequelae were recorded as the underlying, intervening, or contributing causes of death. CLD-related crude annual death rates, 5-year average annual death rates, and average annual percentage changes were estimated.RESULTS:Among male Texas prisoners from 1989 to 2003, CLD-related deaths accounted for 16 of deaths (6884,316). CLD-related crude annual death rates were high and increased over the study period by an average of 4.5 annually, with similar rate increases across categories of race-ethnicity. CLD-related average annual death rates were higher among Hispanic prisoners than among black prisoners in each 5-year period, and were higher than those for white prisoners in the 1994-1998 and 1999-2003 periods. HBV or HCV was identified as a causal factor in more than a third (34) of CLD-related deaths.CONCLUSIONS:From 1989 to 2003, CLD-related death rates among male Texas prisoners were high and increased over time, particularly among Hispanics. Targeted prevention, screening, and treatment of CLD risk factors, especially HCV, and early detection and treatment of CLD should be considered as priorities of the US prison healthcare systems.

AB - OBJECTIVES:Alcohol abuse and chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the major etiologic factors for chronic liver diseasecirrhosis (CLD) in the United States. These CLD risk factors are highly prevalent in US adult incarcerated populations, but CLD-related mortality data from these populations are lacking. The primary objective of this study was to assess CLD-related mortality over time and across categories of race-ethnicity from 1989 through 2003 among male inmates in the Texas state prison system. The secondary objective was to examine patterns of recorded underlying, intervening, and contributing causes of death for CLD-related deaths.METHODS:Prisoner decedent data were linked with Texas Vital Statistics multiple-cause-of-death data. Deaths were considered CLD-related if CLD or common sequelae were recorded as the underlying, intervening, or contributing causes of death. CLD-related crude annual death rates, 5-year average annual death rates, and average annual percentage changes were estimated.RESULTS:Among male Texas prisoners from 1989 to 2003, CLD-related deaths accounted for 16 of deaths (6884,316). CLD-related crude annual death rates were high and increased over the study period by an average of 4.5 annually, with similar rate increases across categories of race-ethnicity. CLD-related average annual death rates were higher among Hispanic prisoners than among black prisoners in each 5-year period, and were higher than those for white prisoners in the 1994-1998 and 1999-2003 periods. HBV or HCV was identified as a causal factor in more than a third (34) of CLD-related deaths.CONCLUSIONS:From 1989 to 2003, CLD-related death rates among male Texas prisoners were high and increased over time, particularly among Hispanics. Targeted prevention, screening, and treatment of CLD risk factors, especially HCV, and early detection and treatment of CLD should be considered as priorities of the US prison healthcare systems.

UR - http://www.scopus.com/inward/record.url?scp=66949146163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66949146163&partnerID=8YFLogxK

U2 - 10.1038/ajg.2009.106

DO - 10.1038/ajg.2009.106

M3 - Article

C2 - 19491854

AN - SCOPUS:66949146163

VL - 104

SP - 1412

EP - 1419

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 6

ER -